Slide 1: Coloplast Earnings Conference Call FY 2016/17
Coloplast Earnings Conference Call FY 2016/17 2 November 2017
Slide 2: Forward-looking statements
Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements
Slide 3: New long-term guidance for the LEAD20 strategy period
Today, Coloplast is presenting a new long-term guidance for the LEAD20 strategy period Revenue growth EBIT margin annual organic constant currencies 7–9% >30% Page 3
Slide 4: Growth acceleration through two key pillars and GOP4 efficiency
Growth acceleration to be driven through two key pillars and GOP4 will continue to drive unparalleled efficiency Two pillars to drive growth I. Accelerated organic investments I. Invest up to 2% of topline p.a. in new investment cases Understanding II. Emerging markets, US, selected countries users’
Slide 5: Full year organic growth of 7% and EBIT margin of 33%
Coloplast delivered full year organic growth of 7% and an EBIT margin of 33% in constant exchange rates Full year highlights Revenue growth +7% • FY organic growth of 7% (6% reported growth). Reported revenue (DKKm) Q4 organic growth of 8% (6% reported growth) +6% Organic growth 15,528 14,681 • FY G
Slide 6: Good performance across all geographies in 2016/17
Good performance across all geographies in 2016/17 with 7% organic growth vs. a market growth of 4-5% FY 16/17 revenue by business area FY 16/17 revenue by geography Business Reported revenue Organic growth Share of organic Geographic Reported revenue Organic growth Share of organic area DKKm growth
Slide 7: EBIT in constant currencies grew 9% in 2016/17
EBIT in constant currencies & before one-off adjustment for VA grew 9% in 2016/17 Comments Full-year EBIT margin development (%) • EBIT before special items grew 4% to DKK 5,024m with a 33.2 reported margin of 32% (33% in constant currencies, before 33.0 one-off revenue adjustment) compared to 33% l
Slide 8: Global Operation Plan 4 supports LEAD20 through efficiency
Global Operation Plan 4 aims to support LEAD20 through continued unparalleled efficiency GOP4 Highlights • Deliver 150 basis points in EBIT margin improvements with full effect from 2020/21 • Driven primarily by continued cost efficiency and procurement savings • Next new volume factories will be lo
Slide 9: New long-term financial guidance and guidance for 17/18
New long-term financial guidance and guidance for 17/18 Guidance 17/18 Guidance 17/18 (DKK) Long term ambition Sales growth ~7% (organic) 5-6% 7-9% p.a. 31-32% (constant >30% (constant EBIT margin ~31% exchange rates) exchange rates) CAPEX (DKKm) ~700 4-5% of sales Tax rate ~23% Page 9
Slide 10: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast A/S - Ostomy Care / C